Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy

Completed · Phase 3 · Has a placebo group

Conditions studied: Sarcoma, Soft Tissue

In brief

A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy

Key facts

Study ID

NCT00753688

Run by

GlaxoSmithKline

People needed

369

Starts

2008-10-01

Expected to finish

2012-12-01

Last updated by the study team

2013-08-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Santa Monica, California, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Minneapolis, Minnesota, United States
• GSK Investigational Site — Clevand, Ohio, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Randwick, New South Wales, Australia
• GSK Investigational Site — Woolloongabba, Queensland, Australia
• GSK Investigational Site — Kurralta Park, South Australia, Australia
• GSK Investigational Site — Hobart, Tasmania, Australia
• GSK Investigational Site — Box Hill, Victoria, Australia
• GSK Investigational Site — Nedlands, Western Australia, Australia
• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — Ghent, Belgium
• GSK Investigational Site — Leuven, Belgium
• GSK Investigational Site — Liège, Belgium
• GSK Investigational Site — Herlev, Denmark
• GSK Investigational Site — Bordeaux, France
• GSK Investigational Site — Lille, France
• GSK Investigational Site — Lyon, France
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.